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In 1999, an infectious disease prevention law was
enacted in Japan that affected the nationwide infectious
surveillance system. A total of 19,304 laboratory-confirmed
verocytotoxin-producing  Escherichia coli cases were
reported through 2004. The annual incidence was
2.74/100,000 population; its fluctuation over time and
space was associated with climate, socioeconomic, and
population factors.
T
riggered by 2 major outbreaks of verocytotoxin-pro-
ducing Escherichia coli (VTEC) in Japan (1,2), the
nationwide surveillance system of the National Institute of
Infectious Diseases (NIID) was reengineered in April 1999
by enacting a new infectious disease prevention law to bet-
ter ascertain the state of laboratory-confirmed VTEC cases
across the nation. In this study, we used these nationwide,
population-based surveillance data to determine the infec-
tious status of VTEC and to explore factors that affect the
incidence of VTEC.
The Study
Since the new surveillance system under the new law
began, all laboratory-confirmed VTEC cases are reported
and counted in Japan. Under this system, stool samples or
rectal swabs are obtained from patients when the clinician
suspects hemorrhagic enterocolitis due to pathogenic E.
coli based on clinical symptoms such as hemorrhagic coli-
tis. These specimens are sent to laboratories at the hospital,
private companies, national institutions in each prefecture,
or the NIID. To maintain high levels of sensitivity and
specificity to detect VTEC, the protocol and training in
these laboratories fall under the guidance of the NIID. At
these laboratories, the specimens are cultured on specific
media such as CHROMagar O157 (Kanto Co. Ltd., Tokyo,
Japan) or cefixime-tellurite sorbitol MacConkey agar
(Oxoid, Unipath Ltd., Hampshire, UK); specific antibodies
against each serotype of E. coli are used (3,4). If the exis-
tence of pathogenic E. coli is confirmed, the ability to pro-
duce verocytotoxin from isolates is investigated by using
reversed passive latex agglutination or a multiplex poly-
merase chain reaction assay (3,5,6).
If the production of verocytotoxin is confirmed by the
laboratory, the case is considered symptomatic VTEC.
Persons associated with the initial case (e.g., family mem-
bers) may be further examined for VTEC at the doctor’s
discretion. When a doctor diagnoses either symptomatic or
asymptomatic VTEC infection, he or she has to report this
event to the local health center immediately and manage
the cases to prevent further spread of the disease. The num-
ber of VTEC cases in Japan is totaled for each prefecture
weekly. In this study, we used this surveillance data report-
ed from April 1999 to October 2004 (287 weeks), which
were retrieved from the Infectious Agents Surveillance
Report published by NIID. Climate variables, which were
summarized weekly, were retrieved from meteorologic
agencies in the capitals of the 47 prefectures. Considering
the incubation period between infection and reporting a
diagnosis of VTEC, we used the climatic conditions from
the 2-week period before each case was reported. We also
used annual socioeconomic data for each of the 47 prefec-
tures (7), including the following information: population
density, percentage of children (<15 years of age), percent-
age of elderly (>65 years of age), average number of per-
sons in the household, number of livestock (beef cattle,
dairy cattle, hogs, and chickens) per person in the prefec-
ture, and average income. All statistical analyses were per-
formed by using Stata 8.0 software (Stata Corp. LP,
College Station, TX, USA). 
Conclusions
Nationwide, 19,304 cases of VTEC were reported dur-
ing the study. The annual incidence was 2.74 per 100,000.
The highest number that occurred in a prefecture was 63
VTEC cases per 1,000,000 during 1 week in a single pre-
fecture. More than 16 VTEC cases were observed in 10%
of 13,489 weeks (287 weeks × 47 prefectures), and no
cases were reported in 57.6% of 13,489 weeks. Age distri-
bution of patients indicates that the number of VTEC cases
was highest in children <5 years of age and fewer cases
were reported in older age groups. A total of 65 outbreaks,
defined as >11 laboratory-confirmed VTEC cases in a cer-
tain time frame and area, were reported during the study.
The biggest outbreak occurred during September 2003 in
Kanagawa prefecture and included 252 symptomatic and
197 asymptomatic cases of VTEC. 
The change in VTEC cases over time is shown in
Figure 1, on which the average air temperature (>25°C)
during each week of the summer season is overlaid.
Though the annual incidence showed no clear tendency to
increase or decrease during this study, a marked seasonal
oscillation pattern with peaks centered in July and August
was shown. 
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100,000 per year in each of the 47 prefectures indicated
that a relatively higher incidence of VTEC was clustered in
western sections of several Japanese prefectures and north-
eastern sections of 2 Japanese prefectures (Figure 2). The
4 prefectures with the highest annual incidences were rural
areas: Saga (9.2/100,000), Ishikawa (7.9/100,000), Akita
(5.8/100,000), and Iwate (5.8/100,000). Conversely, the
prefectures with the lowest incidences were near urban
areas: Yamanashi (1.3/100,000), Ibaraki (1.1/100,000),
Niigata (0.9/100,000), and Shizuoka (1.4/100,000). 
The association of climate and socioeconomic factors
with the fluctuation of VTEC cases was estimated by using
multiple regression analyses (Table). Within the climate
variables, average air temperature of the day, wind speed,
and the number of sunny days were significantly associat-
ed with the incidence of VTEC cases per 100,000 per week
per prefecture. By adjusting for these 3 climate variables
as well as calendar months, associations between 7 socioe-
conomic variables and VTEC incidence/100,000 popula-
tion per week per prefecture were analyzed. Results
indicated that the following population-related factors
were strong risk factors for VTEC incidence: a higher per-
centage of elderly people in the prefecture, higher popula-
tion density, higher number of persons in a household of
the prefecture, and higher percentage of children. The fol-
lowing socioeconomic factors in the prefecture showed a
positive association with VTEC incidence: lower average
income in the prefecture and greater number of beef cattle
per person. On the other hand, the number of chickens per
person was negatively associated with VTEC incidence.
Moreover, this multiple regression model showed that
these population, socioeconomic, and climate factors
could statistically explain 31% of the variability of VTEC
incidence. 
We cannot determine a causal relationship because of
the nature of the ecologic study that we used in this
research. However, the results imply that higher beef cat-
tle density, higher population density, and more persons
per household might increase the risk of developing VTEC
infection. 
Because our surveillance data were collected from dif-
ferent regions of Japan, we compared them on the assump-
tion that 1) people seek care with the same frequency in all
regions when they are ill, 2) doctors request stool speci-
mens with the same frequency in all regions, and 3) labo-
ratories test for VTEC with the same standards in all
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Figure 1. The annual oscillation of verocytotoxin-producing
Escherichia coli (VTEC) cases during the study period. In addition
to the VTEC cases, the average air temperature (>25°C) during
each week of the summer season is overlaid in the graph.
Figure 2. Average number of VTEC cases per 100,000 population
per year in each of 47 prefectures from 1999 to 2004, Japan.regions. Thus, some degree of observation bias may exist
even under control of the law, which is a limitation of this
study. In addition, the number of cases includes not only
symptomatic but also asymptomatic VTEC, which may
also raise the incidence rate in the Japanese surveillance
system.
In conclusion, we showed a high annual incidence of
VTEC of 2.74 per 100,000 that was associated with cli-
mate, socioeconomic, and population factors. However,
because this was an ecologic study, further longitudinal
studies are necessary to address these complicated associ-
ations.
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